+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Somatostatin analogue (SMS 201-995) decreases plasma levels of corticotropin (ACTH) and corticotropin-releasing hormone in a patient with ectopic ACTH-producing tumors

Somatostatin analogue (SMS 201-995) decreases plasma levels of corticotropin (ACTH) and corticotropin-releasing hormone in a patient with ectopic ACTH-producing tumors

Endocrinologia Japonica 37(6): 923-932

Effects of long-acting somatostain analogue (SMS 201-995) on plasma corticotropin (ACTH) and corticotropin-releasing hormone (CRH) levels were studied in a patient (63-year-old woman) with ectopic ACTH-producing tumors associated with type I multiple endocrine neoplasia (MEN-I). The patient had undergone bilateral adrenalectomy. Plasma CRH, as well as plasma ACTH, beta-endorphin and alpha-MSH, increased. The hormone levels were dramatically decreased by acute administration of SMS 201-995. Moderately higher doses of dexamethasone (0.05 or 0.1 mg/kg a day) did not decrease plasma CRH or ACTH. An extremely high dose of dexamethasone (0.2 mg/kg a day), however, decreased plasma ACTH, but failed to decrease plasma CRH. Acute administration of SMS 201-995 further lowered the level of plasma ACTH even in this condition. In addition to the decrease in ACTH, SMS 201-995 decreased plasma CRH. Chronic administration of SMS 201-995 continuously decreased plasma CRH, ACTH and beta-endorphin. The decrease in these hormone concentrations accompanied the disappearance of hyperpigmentation. These results suggested that SMS 201-995 inhibits hypersecretion not only of ACTH but also of CRH, and that the agent is therapeutically useful in normalizing the hypersecretion of these hormones.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 041393391

Download citation: RISBibTeXText

PMID: 1983217

Related references

Somatostatin Analogue(Sms 201-995) Decreases Plasma Levels of Corticotropin(Acth) and Corticotropin-Releasing Hormone in a Patient with Ectopic Acth-Producing Tumors. Endocrinologia Japonica 37(6): 923-932, 1990

The three subtypes of pituitary adrenocorticotropin; basic physiology, quantitative human pharmacology, and medical usefulness of ACTH-corticotropin (corticotropin, crude, U.S.P. corticotropin), ACTX-corticotropin (corticotropin, purified, corticotropin A, type I purified ACTH) and ACTIDE-corticotropin (corticotropin B). A.M.A. Archives of Internal Medicine 92(1): 108-147, 1953

The responses of plasma acth and cortisol to corticotropin releasing hormone and cerebrospinal fluid immunoreactive corticotropin releasing hormone in anorexia nervosa patients. Journal of Clinical Endocrinology & Metabolism 62(2): 319-324, 1986

Studies on ectopic acth producing tumors part 4 corticotropin releasing factor like activity in tumor tissue. Acta Endocrinologica 82(1): 183-192, 1976

In vivo and in vitro ACTH response to ovine corticotropin-releasing factor in a bronchial carcinoid from a patient with ectopic ACTH syndrome. Endocrinologia Japonica 32(4): 577-581, 1985

Dose response relationships between plasma acth cortisol aldosterone and 18 hydroxycorticosterone after injection of acth 1 39 or human corticotropin releasing hormone in man. Journal of Clinical Endocrinology & Metabolism 66(1): 181-186, 1988

Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man. Journal of Clinical Endocrinology and Metabolism 66(1): 181-186, 1988

Ectopic production of ACTH and corticotropin-releasing hormone (CRH). Journal of Steroid Biochemistry and Molecular Biology 43(5): 403-408, 1992

Corticotropin-releasing factor-like activity in ACTH producing tumors. Journal of Clinical Endocrinology and Metabolism 44(3): 440-446, 1977

Gamma melanotropin like immuno reactivities in human pituitaries acth producing pituitary adenomas and ectopic acth producing tumors evidence for an abnormality in glycosylation in ectopic acth producing tumors. Clinical Endocrinology 15(4): 353-362, 1981

Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression. Annals of Neurology 49(3): 304-312, 2001

Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease. Neurology 37(3): 535-538, 1987

Ectopic acth syndrome caused by lung cancer that responded to corticotropin releasing hormone. Journal of Clinical Endocrinology & Metabolism 63(5): 1047-1051, 1986

Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma. Experimental and Clinical Endocrinology and Diabetes 115(1): 13-16, 2007

Bioassay of ACTH using isolated cortex cells. Applications: structure activity relationship for ACTH and analogues, assay of corticotropin-releasing factor, and assay of plasma ACTH. Annals of the New York Academy of Sciences 297: 220-241, 1977